Daclarise Plus
Daclarise Plus
Daclarise Plus is a product of Daclatasvir IP 60mg and Sofosbuvir 400mg. Daclatasvir and sofosbuvir are combinations of antiviral products that help to treat chronic hepatitis C virus. These medications target two different important proteins needed for the HCV lifecycle and stop the virus from spreading.
HIV and ARV Products Manufacturing Company
The mechanism of action involves reducing the Hepatitis C infection load in the body and gradually eliminating the virus from the blood. HCV infection is now widespread worldwide. Hepatitis C-induced liver damage impacts the body through both acute and long-term inflammation. The pathogens spread through contact with sperm, blood, bodily fluids, and human infection. Additionally, it can spread via needle sharing or mother-to-child transmission. Cirrhosis, liver cancer, and liver damage can result from this illness.
Daclatasvir and sofosbuvir are a combination antiviral therapy for chronic hepatitis C (HCV) that works by stopping the virus from replicating and infecting new cells. An NS5A inhibitor that blocks a viral protein important for spread. A nucleotide analog that inhibits the NS5B RNA polymerase; It is a viral enzyme that copies the HCV genome. By working on different parts of the viral replication cycle, the two components work together to stop the virus from multiplying.
Daclatasvir and Sofosbuvir ProductsSunrise Remedies is a trusted manufacturer, exporter, and supplier of Daclatasvir and Sofosbuvir products. The company was founded in 1996. The manufacturing unit is located in Santej, Gujarat.
Sunrise Remedies is the manufacturer of Daclatasvir and Sofosbuvir products under the brand name Daclarise Plus. This combination brand is used in the treatment of viruses and Hepatitis C. The company also manufactures a combination of antiretroviral therapy products. Daclarise Plus is a reliable hepatitis C medicine and offers a trusted single-pill treatment for the virus. Our valuable WHO and GMP certificates ensure the product quality at every stage.
Daclatasvir 60mg and Sofosbuvir IP 400mg.
Indicated for the treatment of chronic hepatitis C (CHC) in adults.
Always take Advise from Your Doctor*